Literature DB >> 16555279

Stable expression of a neuronal dopaminergic progenitor phenotype in cell lines derived from human amniotic fluid cells.

David McLaughlin1, Emmanouella Tsirimonaki, George Vallianatos, Nikolaos Sakellaridis, Theofanis Chatzistamatiou, Catherine Stavropoulos-Gioka, Aspasia Tsezou, Ioannis Messinis, Dimitra Mangoura.   

Abstract

Cells from human amniotic fluid derived from the fetus are considered a source of multipotent cells. Their properties have not been fully exploited, partially because unlike other embryonic sources such as embryonic stem (ES) cells, cell lines from amniocentesis samples have not been generated. We have established and characterized the properties of eight individual cell lines. Flow cytometry using several cell surface markers showed that all cell lines generated consisted of homogeneous populations that lack HLAII antigenicity. Using a combination of immunocytochemistry, Western blotting, and RT-PCR, we found weak expression of Oct4 and nestin and strong expression of tubulin-betaIII, MAP2, and tau. Specific markers for cholinergic, (nor)adrenergic, and GABAergic neurons or glia were weakly expressed or absent, whereas expression of factors implicated in early induction of dopaminergic neurons, TGF-beta3 and beta-catenin were present. Further analysis showed strong expression of EN-1, c-RET, PTX3, and NURR1 essential for induction and survival of midbrain dopaminergic neurons, TH, AADC, and VMAT2 components of dopamine synthesis and secretion, and syntaxin1A and SNAP-25 necessary for neurotransmitter exocytosis. This phenotype was retained throughout passages and up to the current passage 36. Expression of neuronal and dopaminergic markers in individual AF cell lines was comparable to expression in neurons induced from ES cells and in IMR-32 and SH-SY5Y neuroblastomas. Our data show that cell lines can be derived from subcultures of amniocentesis, and are primarily composed of a population of progenitors with a phenotype similar to that of committed mesencephalic dopaminergic neurons. Copyright 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16555279     DOI: 10.1002/jnr.20828

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  22 in total

1.  Stroke therapy: the potential of amniotic fluid-derived stem cells.

Authors:  Maya Elias; Jaclyn Hoover; Hung Nguyen; Stephanny Reyes; Christopher Lawton; Cesar V Borlongan
Journal:  Future Neurol       Date:  2015

Review 2.  Stem cell transplantation: a promising therapy for Parkinson's disease.

Authors:  Yi Wang; Sheng Chen; Dehua Yang; Wei-dong Le
Journal:  J Neuroimmune Pharmacol       Date:  2007-05-09       Impact factor: 4.147

3.  Pitx3 promoter directs Cre-recombinase specifically in a human neuroblastoma cell line.

Authors:  Diana L Castillo-Carranza; Humberto Rodríguez-Rocha; Roberto Montes-de-Oca-Luna; Julio Sepúlveda-Saavedra; Héctor R Martínez; Yolanda López-Vidal; Odila Saucedo-Cárdenas
Journal:  Mol Cell Biochem       Date:  2007-11-30       Impact factor: 3.396

4.  The Co-chaperone BAG2 Mediates Cold-Induced Accumulation of Phosphorylated Tau in SH-SY5Y Cells.

Authors:  Cesar Augusto Dias de Paula; Fernando Enrique Santiago; Adriele Silva Alves de Oliveira; Fernando Augusto Oliveira; Maria Camila Almeida; Daniel Carneiro Carrettiero
Journal:  Cell Mol Neurobiol       Date:  2015-07-25       Impact factor: 5.046

Review 5.  Amniotic fluid cells: current progress and emerging challenges in renal regeneration.

Authors:  Stefano Da Sacco; Laura Perin; Sargis Sedrakyan
Journal:  Pediatr Nephrol       Date:  2017-06-15       Impact factor: 3.714

6.  Oxytocin Increases Neurite Length and Expression of Cytoskeletal Proteins Associated with Neuronal Growth.

Authors:  Z Lestanova; Z Bacova; A Kiss; T Havranek; V Strbak; J Bakos
Journal:  J Mol Neurosci       Date:  2015-10-16       Impact factor: 3.444

7.  Role of amniotic fluid mesenchymal cells engineered on MgHA/collagen-based scaffold allotransplanted on an experimental animal study of sinus augmentation.

Authors:  Paolo Berardinelli; Luca Valbonetti; Aurelio Muttini; Alessandra Martelli; Renato Peli; Vincenzo Zizzari; Delia Nardinocchi; Michele Podaliri Vulpiani; Stefano Tetè; Barbara Barboni; Adriano Piattelli; Mauro Mattioli
Journal:  Clin Oral Investig       Date:  2012-10-14       Impact factor: 3.573

8.  Oxytocin receptor ligands induce changes in cytoskeleton in neuroblastoma cells.

Authors:  Jan Bakos; Vladimir Strbak; Helena Paulikova; Lucia Krajnakova; Zuzana Lestanova; Zuzana Bacova
Journal:  J Mol Neurosci       Date:  2013-01-20       Impact factor: 3.444

Review 9.  Amniotic fluid-derived stem cells for cardiovascular tissue engineering applications.

Authors:  Jennifer Petsche Connell; Gulden Camci-Unal; Ali Khademhosseini; Jeffrey G Jacot
Journal:  Tissue Eng Part B Rev       Date:  2013-03-14       Impact factor: 6.389

10.  Isolation of osteogenic progenitors from human amniotic fluid using a single step culture protocol.

Authors:  Ivana Antonucci; Irene Iezzi; Elisena Morizio; Filiberto Mastrangelo; Andrea Pantalone; Monica Mattioli-Belmonte; Antonio Gigante; Vincenzo Salini; Giuseppe Calabrese; Stefano Tetè; Giandomenico Palka; Liborio Stuppia
Journal:  BMC Biotechnol       Date:  2009-02-16       Impact factor: 2.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.